Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹287Cr
Rev Gr TTM
Revenue Growth TTM
16.17%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

SRD
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -4.7 | -34.6 | -6.2 | 10.8 | -12.2 | 80.7 | 34.6 | 18.6 | 38.6 | 23.8 | 19.4 | -11.1 |
| 83 | 54 | 68 | 83 | 74 | 94 | 91 | 98 | 103 | 116 | 109 | 88 |
Operating Profit Operating ProfitCr |
| 5.1 | 1.8 | 3.5 | 3.9 | 3.4 | 4.9 | 3.9 | 4.1 | 3.6 | 5.1 | 3.4 | 3.0 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | 1 | 2 | 3 | 3 | 5 | 3 | 4 | 4 | 6 | 4 | 2 |
| 3 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
|
Growth YoY PAT Growth YoY% | -83.9 | -90.6 | -65.4 | 96.7 | 60.5 | 500.0 | 36.0 | 20.2 | 44.0 | 21.8 | -6.3 | -27.3 |
| 1.2 | 1.1 | 2.6 | 2.8 | 2.3 | 3.5 | 2.7 | 2.8 | 2.4 | 3.5 | 2.1 | 2.3 |
| 0.2 | 0.1 | 0.3 | 0.4 | 0.3 | 0.5 | 0.4 | 0.5 | 0.4 | 0.7 | 0.4 | 0.3 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 18.5 | 12.3 | 157.5 | 134.0 | -24.6 | 33.9 | 70.8 | 6.7 | -11.0 | 39.6 | 7.6 |
| 22 | 26 | 29 | 73 | 172 | 127 | 165 | 266 | 301 | 278 | 385 | 416 |
Operating Profit Operating ProfitCr |
| 0.9 | 0.9 | 1.4 | 3.1 | 2.3 | 4.2 | 6.8 | 12.3 | 6.8 | 3.3 | 4.1 | 3.8 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 0 | 0 | 0 | 1 | 2 | 4 | 11 | 36 | 21 | 9 | 15 | 15 |
| 0 | 0 | 0 | 0 | 1 | 1 | 3 | 9 | 5 | 2 | 4 | 4 |
|
| | 58.3 | 12.0 | 766.1 | 55.5 | 79.7 | 183.2 | 254.6 | -41.2 | -59.2 | 75.3 | -1.6 |
| 0.3 | 0.4 | 0.4 | 1.3 | 0.8 | 2.0 | 4.3 | 8.9 | 4.9 | 2.3 | 2.8 | 2.6 |
| 0.0 | 0.6 | 0.6 | 2.2 | 0.4 | 0.6 | 1.2 | 1.4 | 2.5 | 1.0 | 1.8 | 1.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 2 | 2 | 2 | 4 | 6 | 8 | 11 | 21 | 64 | 64 | 64 | 64 |
| 6 | 6 | 6 | 17 | 24 | 34 | 39 | 55 | 28 | 35 | 46 | 52 |
Current Liabilities Current LiabilitiesCr | 1 | 2 | 2 | 11 | 27 | 18 | 15 | 28 | 18 | 7 | 19 | 20 |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 1 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 9 | 10 | 10 | 42 | 56 | 59 | 65 | 105 | 109 | 104 | 128 | 136 |
Non Current Assets Non Current AssetsCr | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | -3 | 0 | 0 | -20 | -3 | -6 | 10 | -17 | 15 | 6 | -13 |
Investing Cash Flow Investing Cash FlowCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Financing Cash FlowCr | 2 | 0 | 1 | 20 | 15 | -1 | -5 | 7 | -6 | -11 | 10 |
|
Free Cash Flow Free Cash FlowCr | -3 | 0 | 0 | -20 | -3 | -6 | 10 | -17 | 14 | 6 | -13 |
| -4,248.9 | 138.9 | 83.1 | -2,042.5 | -204.3 | -204.2 | 132.3 | -62.9 | 91.7 | 90.4 | -110.5 |
CFO To EBITDA CFO To EBITDA% | -1,313.8 | 57.1 | 22.3 | -831.7 | -74.9 | -99.6 | 83.4 | -45.7 | 66.4 | 62.3 | -76.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 0 | 0 | 0 | 25 | 33 | 45 | 354 | 892 | 666 | 353 |
Price To Earnings Price To Earnings | 0.0 | 0.0 | 0.0 | 0.0 | 17.0 | 12.2 | 5.9 | 13.1 | 56.0 | 102.1 | 31.0 |
Price To Sales Price To Sales | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.3 | 0.3 | 1.2 | 2.8 | 2.3 | 0.9 |
Price To Book Price To Book | 0.0 | 0.0 | 0.0 | 0.0 | 0.9 | 0.8 | 0.9 | 4.6 | 9.7 | 6.8 | 3.2 |
| 4.2 | 5.8 | 3.6 | 5.2 | 9.2 | 7.8 | 3.8 | 10.1 | 40.9 | 71.0 | 22.5 |
Profitability Ratios Profitability Ratios |
| 2.6 | 2.4 | 2.8 | 15.1 | 7.2 | 8.1 | 10.0 | 14.5 | 10.5 | 5.7 | 5.7 |
| 0.9 | 0.9 | 1.4 | 3.1 | 2.3 | 4.2 | 6.8 | 12.3 | 6.8 | 3.3 | 4.1 |
| 0.3 | 0.4 | 0.4 | 1.3 | 0.8 | 2.0 | 4.3 | 8.9 | 4.9 | 2.3 | 2.8 |
| 2.0 | 2.4 | 3.7 | 6.8 | 7.6 | 9.9 | 19.5 | 38.2 | 20.7 | 9.2 | 12.8 |
| 0.8 | 1.3 | 1.4 | 4.6 | 5.0 | 6.4 | 15.3 | 35.3 | 17.2 | 6.6 | 10.4 |
| 0.7 | 1.0 | 1.1 | 2.3 | 2.7 | 4.5 | 11.7 | 25.7 | 14.5 | 6.2 | 8.8 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Shankar Lal Rampal Dye-Chem Ltd. is a prominent Indian specialty chemical entity currently undergoing a high-stakes strategic pivot. Historically a dominant trader and distributor, the company is transitioning into an **integrated manufacturing powerhouse**. With a recent migration from the **BSE SME Board** to the **BSE Main Board** and a pending application for listing on the **National Stock Exchange (NSE)**, SRDCL is positioning itself for enhanced institutional participation and market liquidity.
---
### **Strategic Pivot: From Trading to Integrated Manufacturing**
The defining characteristic of SRDCL’s current trajectory is its **Backward Integration Strategy**. By internalizing production, the company aims to capture higher margins and insulate itself from the price volatility inherent in pure trading.
* **Manufacturing Expansion:** The company is executing a major project at its **Suwana, Bhilwara** facility. In **January 2026**, the Board authorized an increased investment of **₹1.75 crore** for property acquisition to facilitate this expansion.
* **New Product Verticals:** SRDCL is moving beyond industrial dyes into the high-growth **Home Care and Cleaning** segment. New production lines include:
* **Laundry & Dish Care:** Fabric wash liquids, dish wash gels, and detergent powders.
* **Surface Care:** Floor, toilet, and glass cleaners.
* **Personal Hygiene:** Hand wash formulations.
* **Technological Integration:** To compete with global players, the company is investing in **Industry 4.0** technologies, including **automated production lines**, **AI-powered color-matching**, and digital quality control systems.
---
### **Core Product Portfolio & Market Presence**
SRDCL serves as a critical link in the supply chain for the textile, garment, and sanitization industries. Its operations are anchored by **ISO 9001:2015** and **ISO 14001:2015** certified facilities in **Bhilwara (Rajasthan)** and **Mumbai (Maharashtra)**.
| Segment | Core Focus Areas | Key Products |
| :--- | :--- | :--- |
| **Specialty Dyes** | Textile Dyeing & Printing | **Sulfur Dyes** (Primary Driver), Biodegradable Dyes |
| **Inorganic Chemicals** | Industrial Processing | **Hydrogen Peroxide**, **Sodium Bicarbonate**, **Soda Ash Light** |
| **Sanitization** | Public Health & Water | **Sodium Meta Bi Sulfite**, Water Treatment Chemicals |
| **Consumer Goods** | Home & Personal Care | Detergents, Hand washes, and Industrial Cleaners |
---
### **Financial Performance & Growth Metrics**
The company has demonstrated a robust recovery in the most recent fiscal cycle, characterized by a **75.30% year-on-year growth in profitability** for FY 2024-25.
#### **Comparative Financial Summary (₹ in Lacs)**
| Metric | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **40,178.43** | **28,772.59** | **32,344.91** |
| **Domestic Sales** | **40,157.79** | **28,735.79** | **30,592.80** |
| **Export Sales** | **20.64** | **36.80** | **1,752.10** |
| **Profit Before Tax (PBT)** | **1,542.43** | **867.59** | **1,590.94** |
| **Total Expenses** | **38,636.00** | **27,905.00** | **30,754.00** |
**Key Financial Observations:**
* **Revenue Concentration:** The business is currently **99.9% domestic**, with a strategic focus on the Indian market following a sharp decline in export volumes since FY 2022-23.
* **Capital Structure:** Following a **2:1 Bonus Issue** in July 2022, the paid-up share capital stands at **₹63.97 Crore** (**6,39,66,780 shares** at **₹10 face value**).
* **Solvency:** The **Gearing Ratio** remains conservative at **0.15** (as of March 2025), despite an increase in short-term borrowings to **₹1,785.34 Lacs** to fund operational scaling.
* **Shareholder Returns:** SRDCL maintains a consistent dividend policy, recently recommending **₹0.05 per share (0.50%)**, totaling a **₹31.98 Lacs** payout.
---
### **Operational Resilience & Risk Mitigation**
SRDCL operates in a volatile commodity environment and has established a structured framework to manage market and credit risks.
* **Supply Chain Security:** To counter the **~70% market dominance of Chinese producers**, SRDCL is diversifying its procurement and accelerating its own manufacturing capabilities to reduce third-party dependency, which previously caused cost spikes of up to **30%**.
* **Credit & Liquidity Management:** The company employs a strict credit control mechanism. Receivables are monitored via rolling forecasts, with a policy to write off debts that exceed **2 years** of non-payment.
* **Currency & Interest Hedging:** While the company does not currently hedge raw materials due to the lack of suitable derivative products for its specific chemicals, it manages **Exchange Rate Risk** (addressing the **3-4% annual INR depreciation**) through forward contracts and treasury oversight.
* **Governance:** The appointment of **Mr. Sumit Jain** in April 2026 as a "Techno-Commercial" advisor signals a move toward pharmaceutical-grade quality standards and enhanced corporate governance.
---
### **Sustainability & Regulatory Alignment**
As global regulations like **EU REACH** tighten, SRDCL is aligning its operations with international **ESG (Environmental, Social, and Governance)** standards.
* **Green Chemistry:** Development of low-VOC, water-efficient, and biodegradable dyes to meet the demands of eco-conscious global fashion brands.
* **Environmental Infrastructure:** Implementation of **Zero Liquid Discharge (ZLD)** systems and advanced recycling protocols at manufacturing sites.
* **Policy Synergy:** The company is leveraging Indian government initiatives, including the **PLI (Production Linked Incentive) Scheme**, the **National Chemical Policy**, and the **RoDTEP** scheme to enhance its export competitiveness and reduce import reliance.
---
### **Investment Outlook**
With a shareholder base exceeding **17,000 investors**, Shankar Lal Rampal Dye-Chem Ltd. represents a transition play within the Indian chemical sector. The successful execution of its **backward integration** into home care and specialty manufacturing is the primary catalyst for future margin expansion. While the company faces risks from geographic revenue concentration and global commodity cycles, its disciplined debt management and technological modernization provide a stable foundation for long-term growth.